Examkin

Question

Difficulty: Very hardGastroenterology and Hepatology

A 54-year-old man undergoes an upper gastrointestinal endoscopy for the evaluation of persistent dyspepsia and early satiety. The procedure reveals abnormal, thickened gastric folds in the antrum. Biopsies of the affected area show a dense infiltrate of atypical small lymphocytes in the lamina propria with characteristic lymphoepithelial lesions. Immunohistochemical staining confirms gastric extranodal marginal zone B-cell (MALT) lymphoma. Histologic examination of the non-neoplastic mucosa demonstrates the presence of curved, flagellated, gram-negative bacilli.

Arrange the following steps in the most appropriate chronological order for the definitive evaluation and management of this patient's condition.

  1. 1Endoscopic ultrasound (EUS) for locoregional staging
  2. 2Administration of a proton pump inhibitor and combination antimicrobials
  3. 3Repeat upper gastrointestinal endoscopy with biopsies
  4. 4Involved-site radiation therapy (ISRT)

Answer

The correct chronological sequence is: 1) Endoscopic ultrasound (EUS) for locoregional staging, 2) Administration of a proton pump inhibitor and combination antimicrobials, 3) Repeat upper gastrointestinal endoscopy with biopsies, 4) Involved-site radiation therapy (ISRT).
The evaluation and management of H. pylori-positive gastric MALT lymphoma follows a highly specific sequence. Following histologic diagnosis, endoscopic ultrasound (EUS) is required to determine the depth of wall invasion and regional lymph node involvement, as deeper lesions have lower rates of response to medical therapy. Once staged as early disease, the first-line treatment is H. pylori eradication using a proton pump inhibitor and combination antimicrobials. Because the lymphoma requires time to regress, a repeat upper endoscopy with multiple biopsies is performed several months later to document histologic remission. If the lymphoma persists despite confirmed bacterial eradication, involved-site radiation therapy (ISRT) is the preferred second-line treatment for localized disease.

Step-by-Step Solution

1
Diagnose the underlying condition and its etiology.
Gastric extranodal marginal zone B-cell (MALT) lymphoma associated with Helicobacter pylori.
Biopsies confirm the presence of atypical lymphocytes, lymphoepithelial lesions, and gram-negative bacilli (H. pylori).
2
Determine the necessary initial staging study.
Endoscopic ultrasound (EUS) for locoregional staging.
EUS provides critical information on the depth of invasion (T stage) and regional lymph node status (N stage), which dictate the likelihood of response to medical therapy.
3
Select the initial targeted intervention.
Administration of a proton pump inhibitor and combination antimicrobials.
Eradication of H. pylori is the primary, first-line treatment for early-stage MALT lymphoma, inducing remission in the majority of patients without the need for immediate chemotherapy or radiation.
4
Establish the correct follow-up protocol.
Repeat upper gastrointestinal endoscopy with biopsies.
Histologic regression takes time; a follow-up EGD with biopsies (typically at 3 to 6 months) is necessary to confirm successful H. pylori eradication and lymphoma remission.
5
Identify the appropriate salvage therapy for refractory disease.
Involved-site radiation therapy (ISRT).
If follow-up biopsies demonstrate persistent MALT lymphoma despite successful H. pylori eradication, ISRT is the definitive second-line treatment for localized disease.

Key Concept

The management of H. pylori-positive gastric MALT lymphoma sequentially involves EUS for locoregional staging, antimicrobial eradication therapy, follow-up EGD with biopsy to assess response, and radiation therapy for refractory cases.
Rate this question

Topics

Gastroenterology and Hepatology

More questions from this topic